Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of nivolumab in combination with chemotherapy in stage IIIB/IV or recurrent NSCLC (ONO-4538-04)
jRCT2080222025Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, single-arm trial of nivolumab in non-small cell lung cancer (NSCLC), sponsored by Ono Pharmaceutical. Started Feb 2013; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT2080222025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222025.